Barbara Slusher

Professor

1988 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Barbara Slusher is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Glutamate Carboxypeptidase II Medicine & Life Sciences
Glutamic Acid Medicine & Life Sciences
Glutaminase Medicine & Life Sciences
Diazooxonorleucine Medicine & Life Sciences
eribulin Medicine & Life Sciences
Brain Medicine & Life Sciences
Glutamine Medicine & Life Sciences
Peripheral Nervous System Diseases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

A novel and potent brain penetrant inhibitor of extracellular vesicle release

Rojas, C., Sala, M., Thomas, A. G., Datta Chaudhuri, A., Yoo, S. W., Li, Z., Dash, R. P., Rais, R., Haughey, N., Nencka, R. & Slusher, B., Jan 1 2019, (Accepted/In press) In : British Journal of Pharmacology.

Research output: Contribution to journalArticle

Sphingomyelin Phosphodiesterase
Brain
Astrocytes
Animal Disease Models
Carbamates

Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b + cells and prevents depression-associated behaviors induced by chronic social defeat stress (Neuropsychopharmacology, (2019), 44, 4, (683-694), 10.1038/s41386-018-0177-7)

Zhu, X., Nedelcovych, M. T., Thomas, A. G., Hasegawa, Y., Moreno-Megui, A., Coomer, W., Vohra, V., Saito, A., Perez, G., Wu, Y., Alt, J., Prchalova, E., Tenora, L., Majer, P., Rais, R., Rojas, C., Slusher, B. & Kamiya, A., Jan 1 2019, In : Neuropsychopharmacology.

Research output: Contribution to journalComment/debate

Open Access
Glutaminase
Manuscripts
Brain

DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence

Cuesta, S., Restrepo-Lozano, J. M., Popescu, C., He, S., Reynolds, L. M., Israel, S., Hernandez, G., Rais, R., Slusher, B. & Flores, C., Jan 1 2019, In : Addiction Biology. e12791.

Research output: Contribution to journalArticle

Amphetamine
MicroRNAs
Dopamine
Therapeutics
Down-Regulation

Discovery of Benzamidine- And 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists

Prchalová, E., Hin, N., Thomas, A. G., Veeravalli, V., Ng, J., Alt, J., Rais, R., Rojas, C., Li, Z., Hihara, H., Aoki, M., Yoshizawa, K., Nishioka, T., Suzuki, S., Kopajtic, T., Chatrath, S., Liu, Q., Dong, X., Slusher, B. & Tsukamoto, T., Sep 26 2019, In : Journal of medicinal chemistry. 62, 18, p. 8631-8641 11 p.

Research output: Contribution to journalArticle

G-Protein-Coupled Receptors
HEK293 Cells
Opioid Receptors
Sensory Receptor Cells
Analgesics

Enhanced Oral Bioavailability of 2-(Phosphonomethyl)-pentanedioic Acid (2-PMPA) from its (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl (ODOL)-Based Prodrugs

Dash, R. P., Tichý, T., Veeravalli, V., Lam, J., Alt, J., Wu, Y., Tenora, L., Majer, P., Slusher, B. & Rais, R., Oct 7 2019, In : Molecular Pharmaceutics. 16, 10, p. 4292-4301 10 p.

Research output: Contribution to journalArticle

Prodrugs
Biological Availability
2-(phosphonomethyl)pentanedioic acid
Glutamate Carboxypeptidase II
Pharmacokinetics